US Senator

Angus King 2025-2026 Regular Session - Authored & Sponsored Legislation

Legislative Session

Co-Sponsor of Legislation

US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1000

Introduced
3/12/25  
A bill to establish an Ambassador-at-Large for Arctic Affairs.
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1009

Introduced
3/12/25  
Baltic Security Initiative Act
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1029

Introduced
3/13/25  
Snow Survey Northeast Expansion Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1032

Introduced
3/13/25  
Major Richard Star Act
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1083

Introduced
3/14/25  
Land Manager Housing and Workforce Improvement Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1092

Introduced
3/24/25  
Refer
3/24/25  
WIPPES Act Wastewater Infrastructure Pollution Prevention and Environmental Safety Act
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1101

Introduced
3/25/25  
SHARE Act of 2025 States Handling Access to Reciprocity for Employment Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1115

Introduced
3/25/25  
Paycheck Fairness Act
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1141

Introduced
3/26/25  
Disaster Reforestation Act
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1163

Introduced
3/27/25  
Rural Veterinary Workforce Act
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1172

Introduced
3/27/25  
Honor Farmer Contracts Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1183

Introduced
3/27/25  
Maintaining and Enhancing Hydroelectricity and River Restoration Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1186

Introduced
3/27/25  
Lower Drug Costs for Families Act This bill applies certain Medicare prescription drug rebate requirements to prescription drugs that are available under private health insurance. Current law requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services for brand-name drugs without generic equivalents under Medicare that (1) cost $100 or more per year per individual, and (2) for which prices increase faster than inflation. Manufacturers that fail to comply are subject to civil penalties. The bill applies these requirements to prescription drugs that are available in the commercial market under private health insurance. It also indexes rebate calculations to drug prices in 2016 (as opposed to 2021).
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1233

Introduced
4/1/25  
Keep STEM Talent Act of 2025

Primary Sponsor of Legislation

US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1217

Introduced
3/31/25  
Fishing Industry Credit Enhancement Act of 2025